LINC00240 and esophageal cancer: Further in vitro cell function investigations revealed that knocking down LINC00240 greatly inhibited the rapid growth of esophageal cancer cells and the number of plate clones, suggesting that LINC00240 in esophageal cancer may be a cancer-promoting agent gene, providing new targets for subsequent targeted therapy.